Gene · 8915
Papers2,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the Heterogeneity of Pancreatic Cancer: DNA Methylation-Based Cell Type Deconvolution Unveils Distinct Subgroups and Immune Landscapes. | Epigenomes | 2025 | 40981070 | PubTator, text mining | PubMed |
| B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway. | World J Gastroenterol | 2025 | 40937457 | PubTator, text mining | PubMed |
| Recent Advances in Deciphering Normal and Diseased Aortic Valve Biology Using Transcriptomic Technologies. | J Cell Mol Med | 2025 | 40903834 | PubTator, text mining | PubMed |
| Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy. | Mol Biomed | 2025 | 40877572 | PubTator, text mining | PubMed |
| Epsin1 enforces a condensation-dependent checkpoint for ubiquitylated cargo during clathrin-mediated endocytosis. | Nat Commun | 2025 | 40854908 | PubTator, text mining | PubMed |
| Emodin Alleviates Sepsis-Induced Multiorgan Damage by Inhibiting NETosis through Targeting Neutrophils BCL-10. | Adv Sci (Weinh) | 2025 | 40779122 | PubTator, text mining | PubMed |
| Loss of MALT1 Function in a Patient With Combined Immunodeficiency: a Novel Pathogenic Variant and Immunological Insights. | J Clin Immunol | 2025 | 40748513 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis and the Liver Masquerade. | Cureus | 2025 | 40747175 | PubTator, text mining | PubMed |
| Breaking the oncogenic link: BCL10-MALT1 disruption as a precision strike against NF-κB-driven lymphomas. | Med Oncol | 2025 | 40684038 | PubTator, text mining | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| The CARD14sh-BCL10-MALT1 complex regulates MAVS-mediated antiviral response in keratinocytes. | Proc Natl Acad Sci U S A | 2025 | 40489607 | PubTator, text mining | PubMed |
| A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells. | Leukemia | 2025 | 40425803 | PubTator, text mining | PubMed |
| Laparoscopic distal pancreatectomy for multiple pancreatic solid pseudopapillary neoplasms with marked calcification in a middle-aged female. | Clin J Gastroenterol | 2025 | 40418297 | PubTator, text mining | PubMed |
| Metastatic pancreatic acinar cell carcinoma with BRCA2 gene alternation resected after modified FORFIRINOX therapy: a case report and literature review. | J Gastrointest Oncol | 2025 | 40386586 | PubTator, text mining | PubMed |
| A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma. | J Clin Invest | 2025 | 40231473 | PubTator, text mining | PubMed |
| Multiple regulatory mechanisms, functions and therapeutic potential of chaperone-mediated autophagy. | Theranostics | 2025 | 40083922 | PubTator, text mining | PubMed |
| [A Case of Pancreatic Acinar Cell Carcinoma with Invasive Ductal Carcinoma and Neuroendocrine Tumor]. | Gan To Kagaku Ryoho | 2025 | 40073896 | PubTator, text mining | PubMed |
| Characterization of the atypical antipsychotic drug aripiprazole cytotoxicity in the neutrophil model cell line HL-60. | PLoS One | 2025 | 39937830 | PubTator, text mining | PubMed |
| EMZL at various sites: learning from each other. | Blood | 2025 | 39912633 | PubTator, text mining | PubMed |
| Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax. | Blood Cancer J | 2025 | 39894894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8915/papers?page=3